Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial (Q36374902)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial
scientific article

    Statements

    Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial (English)
    N D Freedman
    T M Curto
    C Morishima
    L B Seeff
    Z D Goodman
    E C Wright
    R Sinha
    J E Everhart
    HALT-C Trial Group
    2 November 2010
    127-137

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit